|
|
![]() |
||||
| Xiaoxi
Zhuang, Ph.D. Associate Professor Department of Neurobiology Committee on Neurobiology |
||||
| The role of dopamine in reward and
reward-dependent behavioral modification
Animal behavior can be largely modified by reward/punishment history. The role of dopamine in reward has been well established. However, how the specific aspects of reward are mediated by dopamine remain to be specified. Using genetically engineered mice, we found that elevated dopaminergic tone enhanced incentive motivation without altering reinforcement learning. We hypothesize that tonic dopamine release is important for incentive motivation whereas it is the phasic dopamine release that may mediate reinforcement learning. We are generating mice with altered phasic dopamine release to test that hypothesis. Ultimately, we are interested in how the role of dopamine in motivation and learning will affect animals' choice behavior in an environment where the availability of food is often associated with food seeking energy cost and/or risks. The molecular basis of dopamine-mediated learning/neuroplasticity could be very different from other types of learning. In the striatum/nucleus accumbens, neuroplasticity requires converged input from corticostriatal projections and dopaminergic projections. We are studying candidate molecular pathways that are unique in this system for dopamine-dependent neuroplasticity to take place. We are using genetic approaches to test the significance of these molecular pathways. The biochemical basis of dopamine neuron degeneration in Parkinson’s disease Parkinson’s disease is caused by the progressive loss of dopamine neurons. However, the biochemical basis of selective dopamine neuron loss is largely unknown. Both oxidative stress and dysfunction of the ubiquitin-proteasome pathway are implicated. We hypothesize that dopamine itself can cause oxidative stress. Under normal conditions, dopamine neurons are able to handle such cellular stress; in aged animals or in animals with genetic defects, dopamine neurons may die when protective mechanisms are impaired (e.g. defects in transporting dopamine to vesicles, defects in protein folding and protein degradation pathways). We are using in vivo transgenic mouse models to test this hypothesis.
|
||||
|
|